Total Funding
30
Total FundingSeries C raised
Growth Score
pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
226676
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Art Krieg: Founder, CSO
David Mauro: Chief Medical OfficerPast Role: Prelude Therapeutics, Chief Medical Officer
About the Company
Checkmate Pharma is a clinical-stage biopharmaceutical company developing a new approach for cancer immunotherapy. The clinical programs are focused on enabling more people with cancer to benefit from the promise of novel immunotherapies. They leveraging their expertise in the field of CpG oligonucleotides to discover and develop immunotherapies
designed to increase the efficacy of existing immunotherapies and to provide new treatment options for patients and their healthcare providers.
Checkmate Pharmaceutical was founded in 2015 and is headquartered in Cambridge, Massachusetts.
